Real-World Study of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol on Asthma Control in the US.

Michael BogartGuillaume GermainFrançois LalibertéMalena MahendranMei Sheng DuhKristi DiRoccoStephen G NoorduynRosirene PaczkowskiRonald Balkissoon

Published in: Journal of asthma and allergy (2023)

In this real-world study, patients with asthma had significantly lower OCS use, asthma-related exacerbations, and SABA use following treatment initiation with FF/UMEC/VI compared with their pre-treatment period. These results suggest better asthma control following initiation of FF/UMEC/VI in a routine clinical practice setting.

Keyphrases

chronic obstructive pulmonary disease
lung function
clinical practice
allergic rhinitis
cystic fibrosis
stem cells
bone marrow
replacement therapy